WebDetails. The AmoyDx® HRD Focus Panel (Reversible Terminator Sequencing) is a next generation sequencing-based in vitro diagnostic test that determines a patient’s HRD status by detecting SNVs and InDels in whole coding regions and intron/exon boundaries of the BRCA1 and BRCA2 genes, and determining a genomic scar score (GSS) using DNA ... WebOct 1, 2015 · AmoyDx offers a portfolio of molecular tests and runs a service center for oncology biomarker analysis. It is also a therapy diagnostics partner for several multinational pharmaceutical companies that offer targeted cancer therapies. The firm says it is the largest provider of molecular diagnostics products for personalized healthcare in China.
Amoy Diagnostics, Haihe Pharmaceutical Ink Agreement to Codevelop …
WebAmoyDx has a rich portfolio of test kits that mainly focuses on oncology target therapy companion diagnostics. All their products are developed in an ISO-13485 certified … WebThe AmoyDx® HANDLE Classic NGS Panel is a next-generation sequencing (NGS) based in vitro diagnostic assay intended for qualitative detection of single nucleotide variants (SNVs), insertions and deletions (InDels), gene fusions, copy number amplifications (CNAs) and microsatellite instability (MSI) in 40 key solid tumour genes, using DNA and RNA … thinking out loud ジャンル
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval …
WebAmoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of … WebAmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan SHANGHAI, China, April 18, … http://www.amoydiagnostics.com/search_con.html?keywords=HRD%20Focus thinking out loud 歌詞